Breast Cancer in Young Women: Joint DFCI-ESO Symposium

The European School of Oncology is pleased to announce the first edition of the Joint ESO-DFCI Breast Cancer in Young Women Symposium", which will be held during the Breast Cancer: New Horizons, Current Controversies Course, on July 15 in Boston, United States.

Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g. etiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment or the consequences of recurrent disease. The Joint ESO-DFCI Breast Cancer in Young Women Symposium is an opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations covering topics on epidemiology, molecular biology, genetics, pathology, surgery, radiotherapy, systemic therapy, survivorship issues (e.g. fertility preservation, psychosocial needs) in young women with breast cancer.


TARGET AUDIENCE
Specific learners include breast cancer Medical Oncologists, Surgical Oncologists, Breast Surgeons, Radiation Oncologists, Registered Nurses, Nurse Practitioners, and other clinicians interested in the care of women and men with breast cancer.


The session will be held during the Breast Cancer: New Horizons, Current Controversies Course.

COURSE ORGANISATION
Ms. Brandee Benton (Course Program Coordinator)
Harvard Medical School
ceprograms@hms.harvard.edu
(617) 384-8600

ESO SESSION ORGANISING SECRETARIAT
Francesca Marangoni
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464525
Fax: +39 02 85464545
Email: fmarangoni@eso.net


VENUE
Boston Marriott Long Wharf
296 State Street
Boston, Massachusetts 02109
USA


ATTENDANCE
Attendance is granted to all participants registered to the course.


FURTHER INFORMATION
To register or view activity information online, click here.
Download here the course announcement.


 

FACULTY
L. Dominici, Assistant Professor of Surgery, HMS
P. Ganz, Professor of Medicine, UCLA
B. Kaufman, Professor of Oncology, Head, Breast Cancer Unit, Sheba Medical Center, Tel Hashomer, Israel
E. Mayer, Assistant Professor of Medicine, HMS
O. Pagani, Clinical Director of the Breast Unit of Southern Switzerland
A.H. Partridge, Associate Professor of Medicine, HMS
F. Peccatori, Director of the Fertility and Reproduction Unit at the European Institute of Oncology in Milan

 15 JULY

8:00		Breast Cancer in Young Women: Joint DFCI / ESO Symposium Chair to be confirmed
8:00		Welcoming Remarks A. Partridge and F.o Peccatori
8:10		Epidemiology, Prevalence and Outcomes A. Partridge
8:35		Hereditary Breast Cancer: Testing and Management in Young Women B. Kaufman
9:00		The Role and Side Effects of Ovarian Suppression O. Pagani
9:25		Reproductive Health & Pregnancy After Breast Cancer P. Ganz
9:50		Treatment of Pregnancy Associated Breast Cancer E. Mayer
10:15		Break
10:30		Psychosocial Issues Unique to Young Women with Breast Cancer Speaker to be confirmed
10:55		How to Build A Program for Young Women with Breast Cancer Speaker to be confirmed
11:20		Local-Regional Treatment Issues in Young Women L. Dominici
11:45		Consensus Statement Comparison: What is unique about “standard” care for young women? Speaker to be confirmed
12:10		Q&A
12:20		Lunch (provided)

13:00-17:00  Breast Cancer in Young Women Research Retreat:  Addressing Unanswered QuestionsSponsored in part by Young and Strong: The Program for Young Women with Breast Cancer at Dana-Farber Cancer Institute and the European School of Oncology, this workshop will focus on ongoing, planned and potential research studies aimed at improving patient care and psychosocial outcomes of young women with breast cancer. This session is not eligible for CME credit.

Please, download here the full course programme.